Athanasios George Tzioufas

Athanasios George Tzioufas's AcademicInfluence.com Rankings

Computer Science

#5772

World Rank

#6092

Historical Rank

Artificial Intelligence

#1888

World Rank

#1920

Historical Rank

Database

#2901

World Rank

#3026

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Athanasios George Tzioufas Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Athanasios George Tzioufas's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force (2015) (1155)
EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome (2009) (727)
Sjögren syndrome (2023) (442)
EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome (2011) (373)
Treatment of primary Sjögren syndrome: a systematic review. (2010) (349)
High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. (1987) (339)
Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. (1996) (242)
Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells. (2019) (241)
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide (2015) (236)
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI) (2014) (231)
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome (2010) (228)
EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies (2019) (221)
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI) (2014) (220)
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial (2007) (211)
Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. (2015) (211)
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. (2006) (205)
Clinically Significant and Biopsy‐Documented Renal Involvement in Primary Sjogren Syndrome (2000) (193)
Pathogenesis of Sjögren's syndrome: what we know and what we should learn. (2012) (189)
Prevalence of Sjögren’s syndrome in a closed rural community (1997) (184)
Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. (2007) (178)
"Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. (2001) (169)
Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome (2016) (169)
Prognosis and Outcome of Non-Hodgkin Lymphoma in Primary Sjögren Syndrome (2012) (168)
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment (2005) (167)
Topical and systemic medications for the treatment of primary Sjögren's syndrome (2012) (155)
Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. (2000) (138)
Peripheral neuropathies in Sjögren's syndrome: a critical update on clinical features and pathogenetic mechanisms. (2012) (138)
Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin (2000) (137)
Classification criteria for Sjogren's syndrome: a critical review. (2012) (134)
Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome. (2013) (132)
Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis (2009) (132)
Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias. (2007) (131)
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19 (2020) (131)
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases (2012) (128)
Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. (2006) (123)
Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic review. (2016) (116)
Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations (2016) (116)
A comprehensive review of autoantibodies in primary Sjögren's syndrome: clinical phenotypes and regulatory mechanisms. (2014) (114)
Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. (2004) (113)
Sjögren’s Syndrome—Study of Autoantigens and Autoantibodies (2007) (112)
B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome. (2014) (107)
Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren's syndrome. (1986) (107)
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unm (2017) (107)
Hypofunction of the stress axis in Sjögren's syndrome. (1998) (106)
Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide (2004) (103)
Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. (2002) (102)
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. (2016) (98)
Classification criteria of Sjögren's syndrome. (2014) (98)
Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study (2011) (97)
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. (2017) (96)
Treatment of rheumatoid arthritis: Unraveling the conundrum. (2015) (95)
Long term remission of Sjögren’s syndrome associated aggressive B cell non-Hodgkin’s lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) (2005) (94)
Classification criteria for Sjögren's syndrome: we actually need to definitively resolve the long debate on the issue (2012) (93)
Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression. (2011) (89)
Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients (2013) (86)
Cryoglobulinaemia (2018) (84)
Outcome measures for primary Sjögren's syndrome: a comprehensive review. (2014) (82)
Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. (2005) (80)
Predicting the Outcome of Sjogren’s Syndrome-Associated Non-Hodgkin’s Lymphoma Patients (2015) (79)
Peripheral neuropathies in Sjögren syndrome: a new reappraisal (2010) (79)
Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. (2012) (78)
Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index (2010) (77)
Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection. (2017) (77)
Prevalence of hepatitis C serum antibody in autoimmune diseases. (2009) (77)
Increased Frequency of Mutations in the Gene Responsible for Familial Mediterranean Fever (MEFV) in a Cohort of Patients with Ulcerative Colitis: Evidence for a Potential Disease-Modifying Effect? (2006) (76)
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis. (2019) (75)
Autoimmune response and target autoantigens in Sjogren’s syndrome (2010) (75)
Clinical picture, outcome and predictive factors of lymphoma in Sjӧgren syndrome. (2015) (72)
Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus: correlation with anemia. (1997) (72)
Sjögren's syndrome. Autoimmune epithelitis. (2000) (72)
Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study (2002) (70)
Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas. (2004) (69)
Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: A controlled study (2013) (68)
A BAFF Receptor His159Tyr Mutation in Sjögren's Syndrome–Related Lymphoproliferation (2015) (67)
Validation of the classification criteria for cryoglobulinaemic vasculitis. (2014) (66)
Sjögren’s Syndrome: Autoantibodies to Cellular Antigens (2000) (65)
The contribution of epigenetics in Sjögren’s Syndrome (2014) (64)
Cross‐reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein (2005) (63)
Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium. (2010) (63)
Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren's syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration. (2016) (62)
Minor Salivary Gland Inflammatory Lesions in Sjögren Syndrome: Do They Evolve? (2013) (61)
Familial Mediterranean fever associated pyrin mutations in Greece (2003) (60)
Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies (2016) (60)
Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. (1999) (58)
Antibody response to the human stress protein BiP in rheumatoid arthritis. (2004) (58)
Mortality in Sjögren's syndrome. (2008) (58)
Medical data quality assessment: On the development of an automated framework for medical data curation (2019) (56)
A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. (2004) (56)
Neuroendocrine Dysfunction in Sjögren’s Syndrome (2008) (56)
B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response. (2010) (56)
The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. (2004) (55)
Primary Sjögren’s syndrome: clinical phenotypes, outcome and the development of biomarkers (2017) (55)
The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): A small pilot study (2013) (55)
Pregnancy outcome and anti-Ro/SSA in autoimmune diseases: a retrospective cohort study. (1998) (53)
2020 international consensus on ANCA testing beyond systemic vasculitis. (2020) (53)
Outcome measures for primary Sjögren's syndrome. (2012) (52)
Serological profiles in subgroups of patients with Sjögren's syndrome. (1986) (51)
Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia. (1999) (51)
Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome (2020) (51)
Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. (1993) (51)
Lymphomagenesis in Sjögren's syndrome: Predictive biomarkers towards precision medicine. (2019) (50)
Autoantibodies in Sjögren's syndrome: clinical presentation and regulatory mechanisms. (2012) (50)
Insight into pathogenesis of Sjögren's syndrome: Dissection on autoimmune infiltrates and epithelial cells. (2017) (50)
The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods (1998) (49)
The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis (2011) (48)
Unmasking the Anti-La/SSB Response in Sera From Patients With Sjogren’s Syndrome by Specific Blocking of Anti-idiotypic Antibodies to La/SSB Antigenic Determinants (2002) (48)
Autoantibodies to intracellular autoantigens and their B-cell epitopes: Molecular Probes to Study the Autoimmune Response (2006) (47)
Primary Sjögren’s syndrome: clinical phenotypes, outcome and the development of biomarkers (2016) (47)
Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study. (2015) (46)
Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis (2015) (44)
Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients (2004) (43)
Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects. (2012) (42)
Enzyme immunoassays for the detection of IgG and IgM anti-dsDNA antibodies: clinical significance and specificity. (1987) (42)
Epigenetic perspectives on systemic autoimmune disease. (2019) (42)
Idiotype, anti-idiotype network of autoantibodies: pathogenetic considerations and clinical application. (2010) (42)
Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin. (1999) (41)
Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens. (2008) (41)
Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome. (2015) (41)
Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands. (1990) (40)
Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia. (2011) (40)
Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sjögren's syndrome (2017) (38)
Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. (2006) (38)
Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs). (1999) (37)
The Role of Chaperone Proteins in Autoimmunity (2006) (37)
Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome (2019) (37)
Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren’s syndrome (2018) (37)
Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects. (2000) (37)
Recurrent pregnancy loss and autoantibody profile in autoimmune diseases. (1999) (36)
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. (2012) (35)
Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. (2011) (34)
Current aspects of pathogenesis in Sjögren’s syndrome (2010) (34)
Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification. (2019) (34)
Ultrasonography of salivary glands: an evolving approach for the diagnosis of Sjögren's syndrome (2008) (33)
Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response. (2003) (33)
Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies (2018) (33)
Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases (1992) (33)
D-penicillamine induced myasthenia gravis: clinical, serological and genetic findings. (1993) (32)
MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome (2017) (31)
Factors related to the presence of autoantibodies in patients with chronic mental disorders (1990) (30)
Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development (2020) (30)
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases (2021) (30)
Fine specificity of antibodies against AQP4: epitope mapping reveals intracellular epitopes. (2011) (30)
Vasculitis in primary Sjögren’s syndrome (1996) (29)
Biomarkers: Saliva proteomics is a promising tool to study Sjögren syndrome (2015) (28)
Lymphoma development in a patient receiving anti-TNF therapy. (2003) (28)
Serum isoamylases in patients with autoimmune rheumatic diseases. (1984) (28)
Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome (2016) (28)
Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease (2015) (27)
Digital gangrene and Raynaud's phenomenon as complications of lung adenocarcinoma. (2004) (27)
Immunopathology of Sjögren's syndrome. (1998) (27)
Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study (2018) (26)
One year in review 2020: pathogenesis of primary Sjögren's syndrome. (2020) (26)
Acquired angioedema: a new target for rituximab? (2004) (25)
International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis. (2020) (25)
Lymphoid Malignancy and Monoclonal Proteins (1987) (25)
The effect of intravenous immunoglobulin (IVIG) treatment on patients with dermatomyositis: a 4-year follow-up study. (2012) (25)
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis (2022) (24)
TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients (2018) (23)
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus. (2020) (23)
B-Cell Epitopes of Intracellular Autoantigens: Myth and Reality (2000) (23)
COVID-19 Immunobiology: Lessons Learned, New Questions Arise (2021) (23)
Risk of myelotoxicity with intravenous cyclophosphamide in patients with systemic lupus erythematosus. (2002) (22)
B-cell lymphoproliferation in primary Sjögren's syndrome. (1996) (22)
Autoantibodies in Greek juvenile chronic arthritis patients. (1991) (22)
Epigenetic modifications in salivary glands from patients with Sjögren's syndrome affect cytokeratin 19 expression. (2016) (22)
Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database. (2017) (21)
Thrombocytopaenia in lupus as a marker of adverse outcome--seeking Ariadne's thread. (2006) (21)
Sjögren’s Syndrome: The Clinical Spectrum of Male Patients (2020) (20)
Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera. (1988) (19)
RNA Recognition Motif (RRM) of La/SSB: The Bridge for Interparticle Spreading of Autoimmune Response to U1-RNP (2010) (18)
Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study (2010) (18)
Salivary Gland Ultrasonography in Sjögren's Syndrome: A European Multicenter Reliability Exercise for the HarmonicSS Project (2020) (17)
Functional expression of the alpha 2-macroglobulin receptor CD91 in salivary gland epithelial cells. (2009) (17)
Impaired elastic properties of ascending aorta in patients with giant cell arteritis (2004) (16)
Thrombocytopenia in lupus: baseline C3 as an independent risk factor for relapse (2006) (16)
Autoantibodies in Autoimmune Diseases: Clinical and Critical Evaluation. (2016) (16)
Cohort Harmonization and Integrative Analysis From a Biomedical Engineering Perspective (2019) (16)
Increased frequency of the PTPN22W* variant in primary Sjogren's Syndrome: Association with low type I IFN scores. (2016) (16)
Multiple primary squamous cell carcinomas of the lower lip and tongue arising in discoid lupus erythematosus: a case report. (2018) (15)
Autoantibodies to HMG-17 nucleosomal protein in autoimmune rheumatic diseases. Correlation with systemic lupus erythematosus clinical activity and with antibodies to double-stranded DNA. (1993) (15)
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease. (2020) (15)
Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity (2015) (15)
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review (2021) (15)
Determination of anti-ds-DNA antibodies by three different methods: Comparison of sensitivity, specificity and correlation with lupus activity index (LAI) (1990) (14)
Sjögren's syndrome towards precision medicine: the challenge of harmonisation and integration of cohorts. (2019) (14)
Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis. (2016) (14)
Radiomics-Based Assessment of Primary Sjögren's Syndrome From Salivary Gland Ultrasonography Images (2020) (14)
No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs). (2000) (14)
Sialochemistry of patients with autoimmune rheumatic disease with and without histological manifestations of Sjögren's syndrome. (1985) (14)
Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus. (2008) (14)
A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score. (2021) (13)
Longterm Followup After Tapering Mycophenolate Mofetil During Maintenance Treatment for Proliferative Lupus Nephritis (2011) (13)
Ovarian function is preserved in women with severe systemic lupus erythematosus after a 6-month course of cyclophosphamide followed by mycophenolate mofetil. (2010) (13)
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome. (2017) (13)
Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance (2021) (13)
Sjögren's syndrome: an oligo-monoclonal B cell process. (1990) (13)
Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations (2016) (13)
Predicting lymphoma outcomes and risk factors in patients with primary Sjögren’s Syndrome using gradient boosting tree ensembles (2019) (12)
Zinc ion dependent B-cell epitope, associated with primary Sjogren's syndrome, resides within the putative zinc finger domain of Ro60kD autoantigen: physical and immunologic properties. (2004) (12)
Indications for bone marrow examination in autoimmune disorders with concurrent haematologic alterations. (2013) (12)
Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study. (2017) (12)
Cryoglobulinemia in primary Sjögren's syndrome: a monoclonal process. (1986) (12)
Imaging: Diagnostic value of ultrasonography in Sjögren's syndrome (2014) (11)
Towards the Establishment of a Biomedical Ontology for the Primary Sjögren’s Syndrome (2018) (11)
Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece (2020) (11)
Neutrophil extracellular traps in giant cell arteritis biopsies: presentation, localization and co-expression with inflammatory cytokines. (2021) (11)
Update on Sjögren’s Syndrome 2018 (2018) (10)
Ablation of the Chaperone Protein ERdj5 Results in a Sjögren's Syndrome-Like Phenotype in Mice, Consistent With an Upregulated Unfolded Protein Response in Human Patients (2019) (10)
Overcoming the Barriers That Obscure the Interlinking and Analysis of Clinical Data Through Harmonization and Incremental Learning (2020) (10)
Genetic Variability as a Regulator of TLR4 and NOD Signaling in Response to Bacterial Driven DNA Damage Response (DDR) and Inflammation: Focus on the Gastrointestinal (GI) Tract (2017) (10)
Analysis of NLRP3, MVK and TNFRSF1A variants in adult Greek patients with autoinflammatory symptoms. (2018) (10)
[Sjögren syndrome. New therapeutic approaches]. (2005) (10)
SARS-CoV-2 Antigenemia as a Confounding Factor in Immunodiagnostic Assays: A Case Study (2021) (10)
Thoracoabdominal motion in ankylosing spondylitis: association with standardised clinical measures and response to therapy (2008) (10)
Polyreactive antibodies in the circulation of patients with systemic lupus erythematosus (2015) (9)
Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis (2019) (9)
Clinical significance of autoantibodies to Ro/SSA and La/SSB (1996) (9)
OP0217 Defining Disease Activity Sates and Minimal Clinically Important Improvement (MCII) with the EULAR Primary SjÖGren's Syndrome Disease Activity Index (ESSDAI) (2014) (9)
Autoantibodies to HMG-17 nucleosomal protein in patients with scleroderma. (1994) (9)
Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders (2021) (9)
Incidence and Prevalence of Major Central Nervous System (CNS) Involvement in Systemic Lupus Erythematosus (SLE): A 3 Year Prospective Evaluation and Clinical Correlations in 456 Patients (S08.004) (2012) (9)
Common and rare forms of vasculitis associated with Sjögren's syndrome. (2019) (9)
Non-invasive vascular biomarkers in patients with Behçet's disease: review of the data and future perspectives. (2017) (9)
Limited efficacy of targeted treatments in Sjögren's syndrome: why? (2018) (9)
Linear epitopes of two different autoantigens-La/SSB and myelin basic protein--with a high degree of molecular similarity, cause different humoral immune responses. (2003) (8)
Reactivity to AQP4 epitopes in relapsing–remitting multiple sclerosis (2013) (8)
Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study. (1995) (8)
Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar disease (2016) (8)
A B-Cell Activating Factor Receptor (BAFF-R) His159Tyr Mutation in Sjogren's Syndrome Related Lymphoproliferation (2015) (8)
Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development. (2020) (8)
Bioenergetic Profiling of the Differentiating Human MDS Myeloid Lineage with Low and High Bone Marrow Blast Counts (2020) (7)
Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice. (2007) (7)
Circulating antibodies to prothymosin alpha in systemic lupus erythematosus. (1989) (7)
Punctal occlusion in Sjögren's syndrome needs clarification (2012) (7)
Cyclophosphamide followed by rituximab for aggressive multiple-relapsing antineutrophil cytoplasmic antibody-associated vasculitis. (2017) (7)
Validation of thymic stromal lymphopoietin as a biomarker of primary Sjögren's syndrome and related lymphoproliferation: results in independent cohorts. (2020) (7)
Alveolar type II cells harbouring SARS-CoV-2 show senescence with a proinflammatory phenotype (2021) (7)
Enhancing medical data quality through data curation: a case study in primary Sjögren's syndrome. (2019) (6)
Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome (2021) (6)
Glomerular Diseases Associated with Malignancies: Histopathological Pattern and Association with Circulating Autoantibodies (2020) (6)
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4 (2015) (6)
Subclinical manifestations of autoimmune rheumatic diseases in primary Raynaud's phenomenon. (1985) (6)
Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease (2021) (6)
SARS-CoV-2 infects lung epithelial cells and induces senescence and an inflammatory response in patients with severe COVID-19 (2021) (6)
FRI0303 Validation of eular primary sjögren’s syndrome disease activity and patient indexes (2012) (6)
Complete heart block in a patient with systemic sclerosis (2006) (6)
SP0190 2019 EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF SJöGREN”S SYNDROME WITH TOPICAL AND SYSTEMIC THERAPIES (2019) (6)
Corrigendum: Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements [Rheumatology, 54, (2015) (2230-2238)] DOI: 10.1093/rheumatology/kev200 (2017) (6)
Type-III interferons in Sjögren's syndrome. (2020) (5)
Prevalence of Non-Organ-Specific Autoantibodies in Pregnant and Non-Pregnant Healthy Women (1992) (5)
Sjögren’s Syndrome: From Polyclonal B Cell Activation to Monoclonal B Cell Proliferation (1994) (5)
Predictors of renal histopathology in antineutrophil cytoplasmic antibody associated glomerulonephritis. (2016) (5)
Combined seronegativity in Sjögren's syndrome. (2021) (5)
Sjögren-like Disease and Silicone Implants A Greek Experience. (1998) (5)
Periodic fevers in adult Greeks: clinical and molecular presentation. (2014) (5)
OP0079 Salivary Gland Epithelial Cells (SGECS) Promote the Differentiation of B Cells (2013) (5)
Epigenetic alterations in Sjögren’s syndrome patient saliva (2020) (5)
Dealing with Open Issues and Unmet Needs in Healthcare Through Ontology Matching and Federated Learning (2020) (5)
New frontiers in precision medicine for Sjogren’s syndrome (2021) (5)
A computational pipeline for data augmentation towards the improvement of disease classification and risk stratification models: A case study in two clinical domains (2021) (5)
Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren’s Syndrome (2021) (5)
A computational workflow for the detection of candidate diagnostic biomarkers of Kawasaki disease using time-series gene expression data (2021) (4)
The necessity of novel biomarkers in primary Sjögren's syndrome. (2019) (4)
Patient with ankylosing spondylitis and scleroderma renal crisis (2018) (4)
Autophagy in Myelodysplastic Syndromes: The Role of HIF-1a/REDD1 Molecular Pathway (2018) (4)
Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma? (2021) (4)
Non-organ specific autoantibodies against cellular components in HIV-1 infected individuals. (1997) (4)
Treatment of Primary Sjögren Syndrome (2010) (4)
How can autoantibodies predict the long-term outcome of patients with interstitial lung disease? Results from a retrospective cohort study. (2018) (4)
Severe aortic stenosis and mitral regurgitation in a woman with systemic lupus erythematosus (2002) (4)
Demographics, clinical characteristics and predictive factors for total knee or hip replacement in patients with rheumatoid arthritis in Greece. (2013) (4)
Searching for the "X factor" in Sjögren's syndrome female predilection. (2021) (4)
Utilizing Incremental Learning for the Prediction of Disease Outcomes Across Distributed Clinical Data: A Framework and a Case Study (2019) (4)
Deregulation of the Kallikrein Protease Family in the Salivary Glands of the Sjögren’s Syndrome ERdj5 Knockout Mouse Model (2021) (4)
Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral center. (2020) (3)
FRI0421 Development of Clinessdai Score (Clinical Eular Sjögren's Syndrome Disease Activity Index) Without Biological Domain: A Tool For Biological Studies (2015) (3)
Antiphospholipid and Antinuclear Antibodies in Children with Idiopathic Epilepsy: A 2-Year Prospective Study (2019) (3)
Glandular Epithelium: Innocent Bystander or Leading Actor? (2016) (3)
THU0204 ASSOCIATION OF LILRA3 GENE WITH LYMPHOMAGENESIS RISK IN YOUNG SS PATIENTS (2019) (3)
T cell lymphoma in the setting of Sjögren's syndrome: T cells gone bad? Report of five cases from a single centre cohort. (2020) (3)
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’ (2021) (3)
Predicting Lymphoma Development by Exploiting Genetic Variants and Clinical Findings in a Machine Learning-Based Methodology With Ensemble Classifiers in a Cohort of Sjögren's Syndrome Patients (2020) (3)
Exploiting the Role of Hypoxia-Inducible Factor 1 and Pseudohypoxia in the Myelodysplastic Syndrome Pathophysiology (2021) (3)
Decrease in the ratio of polyreactive IgG titers with IgG concentration is associated with long-term complications of primary Sjögren's syndrome. (2018) (3)
THU0298 Type I Interferon Predicts Biological Effect of Belimumab on Rheumatoid Factor Positive B-Cells in Sjögren's Syndrome: Results from The Beliss Trial (2016) (3)
Variation in primary Sjögren's syndrome care among European countries. (2019) (3)
Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren’s Syndrome (2021) (3)
SAT0208 TEN-YEAR OVERALL SURVIVAL AND STANDARIZED MORTALITY RATIO IN THE LARGEST SINGLE CENTER COHORT OF PATIENTS WITH PRIMARY SJOGREN’S ASSOCIATED LYMPHOMAS (2019) (3)
Monoclonal expansion of B cells in Sjögren's syndrome: comment on the article by Martin et al. (2001) (3)
Pathogenetic Aspects of Primary Sjögren’s Syndrome (2011) (3)
Panniculitis: an unusual presenting manifestation of rheumatoid arthritis. (2016) (3)
A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness. (2021) (3)
Addressing the clinical unmet needs in primary Sjögren’s Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts (2022) (3)
Multiple additive regression trees with hybrid loss for classification tasks across heterogeneous clinical data in distributed environments: a case study (2021) (3)
Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target? (2020) (3)
Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases Part 2. (2020) (3)
Current Concepts in SLE Thrombocytopenia: From Pathophysiology to Therapeutic Interventions (2006) (3)
Salivary gland imaging techniques for the diagnosis of Sjögren’s syndrome (2009) (3)
Extensive phenotyping of vascular damage in non-infectious primary vasculitides with the use of non-invasive vascular biomarkers: prevalence, pathogenesis and response to treatment (2018) (3)
Epitopes and complementary epitopes of autoantigens: candidate probes to study and modulate the autoimmune response. (2002) (3)
Leukaemic synovitis. (2006) (3)
FRI0222 ANALYSIS OF CLINICAL AND SEROLOGICAL PICTURE OF PATIENTS WITH PRIMARY SJöGREN’S SYNDROMEAND AN EARLY DISEASE ONSET AT AGE BEFORE 35 YEARS (2019) (2)
B-cell chronic lymphocytic leukaemia presenting as lower motor neuron disease and SS. (2012) (2)
FRI0313 DIFFERENTIAL PERFORMANCE OF NAILFOLD VIDEO CAPILLAROSCOPIC PARAMETERES IN THE DIAGNOSIS AND PROGNOSIS OF SYSTEMIC SCLEROSIS (2019) (2)
B-Cell Targeted Therapies in Primary Sjögren Syndrome (2014) (2)
Corrigendum to “Idiotype, anti-idiotype network of autoantibodies: Pathogenetic considerations and clinical application [J. Autoimmun. Rev. 9(2010) 631–633] (2012) (2)
COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases (2022) (2)
Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies (2022) (2)
Predicting lymphoma in Sjögren’s syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording (2022) (2)
EULAR Sjögren's syndrome study group: an eSSential way to address the unmet needs of the disease. (2020) (2)
Severe cutaneous hand infection: Mycobacterium marinum in an immunosuppressed patient. (2018) (2)
Treatment Approaches in Primary Sjögren Syndrome—Reply (2010) (2)
DNA Methylation Studies in Saliva of Patients with Sjögren’s Syndrome (2021) (1)
OP0294 SJÖGREN’S SYNDROME ASSOCIATED LYMPHOMAS: CLINICAL DESCRIPTION AND 10-YEAR SURVIVAL (2021) (1)
Quality of life in patients with Graves’ orbitopathy (2020) (1)
A De-centralized Framework for Data Sharing, Ontology Matching and Distributed Analytics (2018) (1)
A Training Tool to support the management and diagnosis of Sjögren's syndrome. (2020) (1)
Autoimmune epithelitis beyond the exocrine glands: an unusual case of anti-Ro/La and Scl-70 lymphocytic interstitial pneumonia. (2019) (1)
Highprevalence ofanti-cardiolipin andother autoantibodies inahealthy elderly population (1987) (1)
Interaction of Human Salivary Gland Epithelial Cells with B Lymphocytes: Implications in the Pathogenesis of Sjögren’s Syndrome (2020) (1)
THU0265 THYMIC STROMAL LYMPHOPOIETIN (TSLP) AS A BIOMARKER OF PRIMARY SJÖGREN’S SYNDROME (PSS) AND RELATED LYMPHOMA: VALIDATION IN INDEPENDENT COHORTS (2020) (1)
Book Review: Rheumatology in Questions (2020) (1)
Role of miR200b-5p miRNA in lymphomagenesis associated with Sjögren’s syndrome (SS) (2018) (1)
Liver Fibrosis in Primary Sjögren’s Syndrome (2022) (1)
P2_118 Central Nervous System involvement in patients with Granulomatosis with Polyangiitis: A single center experience (2017) (1)
SAT0190 LYMPHOMA IN PRIMARY SJÖGREN’S SYNDROME: A RETROSPECTIVE CLINICAL STUDY WITH PATIENTS FROM THE UPA (UDINE, PISA, ATHENS) GROUP (2019) (1)
Predicting autoimmune congenital heart block: is it feasible and how? (2007) (1)
Gynecological and Reproductive Complications in Primary Sjögren’s Syndrome (2011) (1)
OP0131 COMPARISON OF CLINICAL PHENOTYPE, SEROLOGICAL CHARACTERISTICS AND HISTOLOGIC FEATURES OF MALES VS FEMALES PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) (2019) (1)
AB0166 ENHANCING THE QUALITY OF CLINICAL DATA THROUGH DATA CURATION IN PRIMARY SJöGREN’S SYNDROME (2019) (1)
Patient-reported experience and health-related quality of life in patients with primary Sjögren's syndrome in Europe (2021) (1)
58-year-old patient with IgG4-related thoracic aortitis (2016) (1)
Epigenetic modifications affect cytokeratin 19 expression in salivary glands from patients with Sjögren's syndrome. (2016) (1)
Identification of Symptomatic and Asymptomatic Small Fiber Neuropathy (SFN) in Patients with Rheumatic Disorders (P01.142) (2013) (1)
Sjogren’s Syndrome (Ss) in Progressive Systemic Sclerosis (SSc) (2020) (1)
Experimental models of Sjögren's syndrome: differences and similarities with human disease. (2022) (1)
Incidence of autoantibodies related to systemic autoimmunity in patients with severe COVID-19 admitted to the intensive care unit. (2022) (1)
The Effect of Anakinra, an IL-1 Receptor Antagonist, in Patients with Inclusion Body Myositis (sIBM): A Small Pilot Study (P07.224) (2012) (1)
Epitopes of Autoantigens and their Role in Initiation and Propagation of Systemic Autoimmunity (2009) (1)
B-cell Epitopes of Sjögren’s Syndrome-Related Autoantigens Ro/SSA and La/SSB (2011) (1)
THU0137 Effectiveness and Adverse Reactions of Long-Term Use of Biologic Agents in Patients with Rheumatoid Arthritis: A Retrospective Study (2013) (1)
Autoimmune or infectious disease? That is the question. (2018) (1)
Occurrence and Antigenic Specificity of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) in Systemic Autoimmune Diseases (2021) (1)
AB0527 PREDICTIVE VALUE OF MIR200B-5P IN THE LYMPHOMAGENESIS IN SJÖGREN’S SYNDROME (SS): COMPARISON WITH THE PUBLISHED PREDICTION MODELS. PRELIMINARY RESULTS (2019) (1)
Autoantibodies in Sjögren’s Syndrome and Laboratory Markers (2016) (1)
[Monoclonal cryoglobulins in primary Sjögren's syndrome]. (1988) (1)
Idiopathic retroperitoneal fibrosis: clinical features, treatment modalities, relapse rate in Greek patients and a review of the literature (2021) (1)
Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study. (2023) (1)
Identification of Antibodies Against Inositol 1,4,5-Triphosphate Receptor 1 (IR3R1) in Cerebellar Ataxia and Primary Progressive Multiple Sclerosis (S30.002) (2016) (0)
OP0083 RO52/TRIM21 Expression in Salivary Gland Epithelial Cells (SGECS) is Upregulated by TLR3-Signaling (2013) (0)
AB0266 Treat-To-Target Biologic Therapy in Patients with Rheumatoid Arthritis Has A Safer Profile Compared To Delayed Initiation of Biologics (2016) (0)
AB0511 INTERNATIONAL CONSENSUS ON ANCA TESTING AND INTERPRETATION BEYOND SYSTEMIC VASCULITIS (2020) (0)
patients . marker for rheumatoid arthritis in Greek Examination of HLA-DR 4 as a severity (2004) (0)
Extraordinary extrahaematological manifestations of chronic myelomonocytic leukaemia (2020) (0)
MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome (2017) (0)
Anti-Aquaporin 4 Autoantibodies in Patients with Systemic Lupus Erythematosus without CNS Involvement: A Long-Term Assessment (P5.036) (2014) (0)
Current Treatment of Extraglandular Manifestations with Disease-Modifying and Immunosuppressive Agents (2011) (0)
NeutraSal ® is clinically proven to help restore the oral environment 2 FOR PATIENTS WITH SJÖGREN ’ S SYNDROME 90 % OF PATIENTS REPORTED IMPROVEMENT IN SWALLOWING (2017) (0)
Sjögren’s Syndrome: The Significance of Epithelial Cells (1999) (0)
Conformational study of the complementary peptide to a B-cell epitope of the La/SSB autoantigen (2001) (0)
Scoring Primary Sjögren's syndrome affected salivary glands ultrasonography images by using deep learning algorithms (2021) (0)
Patient-centered approaches for patients with systemic autoimmune rheumatic diseases: development and evolution (2022) (0)
Abstracts for the 5th Turkish-Greek Rheumatology Days, October 14-16, 2011, Belek, Antalya Oral Presentations (2011) (0)
Abstracts for the 5th Turkish-Greek Rheumatology Days, October 14-16, 2011, Belek, Antalya Oral Presentations (2011) (0)
THU0294 THE DIFFERENCES IN THE CLINICAL SPECTRUM OF CRYOGLOBULINEMIC VASCULITIS BETWEEN SJÖGREN’S SYNDROME AND HCV HEPATITIS (2020) (0)
Differences between Unilateral and Bilateral Graves' Orbitopathy. An observational study (2023) (0)
Author and Subject Index (2000) (0)
FRI0001 Good Response after Three Months of Treatment with Biologic Agents May PREDICT Long-Term Efficacy of Biologic Treatment in Patients with Rheumatoid Arthritis (2014) (0)
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4. (2015) (0)
OP0291 SEVERITY OF LABIAL MINOR SALIVARY GLAND FOCUS SCORE AND FUTURE LYMPHOMA DEVELOPMENT IN SJÖGREN’S SYNDROME (2021) (0)
The clinical phenotype of primary Sjögren's syndrome patients with lymphadenopathy. (2022) (0)
Autoimmune phenomena in myelodysplastic syndromes: A four year prospective study (2004) (0)
The clinical and technical impact of the HarmonicSS project. (2021) (0)
POS0829 SPECIFICITY OF PANCA AUTOANTIBODIES IN AUTOIMMUNE DISEASES (2021) (0)
Top Stories 7 Clinician ’ s Corner – Nail Capillaroscopy in SS 9 New Partnerships for 2010 SSF Student Fellowships 15 Patient Education – Anti-Inflammatory Diet (2010) (0)
Clinical aspects of autoimmunity (2004) (0)
Pathophysiology of Sjögren's-like syndrome induced by cancer immunotherapies: similarities and differences with classical Sjögren's syndrome. (2022) (0)
FRI0297 CLINICAL FEATURES, TREATMENT MODALITIES AND RELAPSE RATES IN GREEK PATIENTS WITH RETROPERITONEAL FIBROSIS (2019) (0)
Clinical and laboratory findings of primary Sjögren's syndrome patients without sicca symptoms. (2022) (0)
Bilateral dilation of the urinary tract due to iliopsoas pyomyositis: a case report (2011) (0)
Chapter 7 Digestive Involvement in Primary Sjögren's Syndrome (2008) (0)
MicroRNA (miRNA) molecules as candidate regulators of Ro/SSA and La/SSB mRNA expression in Sjögren's syndrome (2012) (0)
Osteogenesis Imperfecta (OI) Type 2-B or 3: Investigating the Survivorship of a Patient (2020) (0)
08.37 Thrombospondin-1 is highly expressed by salivary gland epithelial cells of sjögren’s syndrome patients, both constitutively and upon exposure to necrotic cells debris (2017) (0)
Sjögren's Syndrome: current knowledge and future prospects (2018) (0)
Validation Study Of The International Classification Criteria For TheCryoglobulinemic Vasculitis (2013) (0)
Akt Signaling Pathway Is Activated in the Minor Salivary Glands of Patients with Primary Sjögren’s Syndrome (2021) (0)
THU0044 Efficacy of Treat-To-Target Biologic Therapy in Patients with Rheumatoid Arthritis Compared To Delayed Initiation of Biologics: A Real World Study (2016) (0)
DEFECTIVE DNA METHYLATION IS ASSOCIATED WITH SSB GENE EXPRESSION, ANTI-SSB/LA DETECTION, AND LYMPHOCYTE INFILTRATION IN SALIVARY GLAND EPITHELIAL ACINI FROM PATIENTS WITH SJOGREN’S SYNDROME (2016) (0)
A pilot trial of Canakinumab (Ilaris), an IL-1β Receptor antagonist, in the treatment of patients with sporadic Inclusion Body Myositis (sIBM) (P3.444) (2018) (0)
Kinetics of Mononuclear Cell Subpopulations in the Peripheral Blood of Patients with Giant Cell Arteritis During the Acute Phase of the Disease: The Role of Steroids (2022) (0)
Preliminary Pages / Contents (2000) (0)
THU0012 BAFF Genetic Variants in Lymphomagenesis Associated with Sjogren’s Syndrome (2013) (0)
Vitamin D levels in patients with graves orbitopathy (2022) (0)
AB0697 ANTI-SARS-COV-2 ANTIBODIES AND AUTOANTIBODIES IN COVID-19 PATIENTS SURVIVED AFTER ICU ADMISSION, 6 MONTHS LATER (2021) (0)
The prevalence of intestinal metaplasia in APCA positive patients with Graves disease (2021) (0)
A federated AI strategy for the classification of patients with Mucosa Associated Lymphoma Tissue (MALT) lymphoma across multiple harmonized cohorts (2021) (0)
07.08 Contribution of mthfr gene polymorphisms in primary sjögren’s syndrome related lymphomagenesis (2017) (0)
Epigenetics factors analysis in Sjögren Syndrome (2017) (0)
Abstract—Mucosa Associated Lymphoma Tissue (MALT) type is an extremely rare type of lymphoma which occurs in less than 3% of patients with primary Sjögren’s Syndrome (2021) (0)
FRI0149 THE CLINICAL FEATURES OF SJÖGREN’S SYNDROME PATIENTS WITH EARLY AND LATE DISEASE ONSET (2020) (0)
Structural insights into antigenicity of Ro/La ribonucleoprotein: SLE related epitopes are cryptic, masked by hY1 RNA (2010) (0)
Response to: ‘Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?’ by Nocturne et al (2018) (0)
AB0537 PSORIATIC ARTHRITIS BURDEN, QUALITY OF LIFE AND FUNCTIONAL ABILITY IMPAIRMENTS IN PATIENTS INITIATED ON APREMILAST IN THE ROUTINE CARE IN GREECE: INTERIM RESULTS FROM THE MULTICENTER PROSPECTIVE STUDY “APROACH” (2021) (0)
Prevalence of double vision (diplopia) and strabismus in patient with Graves orbitopathy (2021) (0)
Cl in ic ian ’ s Corner Systemic Activity at Diagnosis of Sjögren ’ s : A Key Prognostic Marker (2015) (0)
resolve the long debate on the issue syndrome : we actually need to definitively Classification criteria for Sjögren ' s (2013) (0)
Risk factors for lymphoproliferation and mortality in Sjögren’s syndrome (2006) (0)
Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease (2022) (0)
Origin, antigenic specificity and regulation of autoantibodies targeting Ro/La RNP. (2004) (0)
SARS-CoV-2 antigenemia/viremia masks seroconversion in a COVID-19 patient (2021) (0)
The Professionals ’ Resource on Sjögren ’ s Syndrome First Genetic Associations Established for Sjögren ’ s (2014) (0)
POS0290 PREDICTING RISK FACTORS OF MALT LYMPHOMA IN SJÖGREN’S SYNDROME (2021) (0)
A past medical history of autoimmune disease predicts a future with fewer relapses in patients with ANCA-associated vasculitis. (2022) (0)
B Cell Epitope Mapping of Aquaporin-4 (AQP4) and Reactivity to AQP4 Epitopes in Neuromyelitis Optica (NMO) and Relapsing-Remitting Multiple Sclerosis (RRMS) (P02.131) (2012) (0)
Dr. Laskari, et al reply (2011) (0)
FRI0012 THE CLINICAL SPECTRUM AND PEDIGREE ANALYSIS OF TRAPS IN GREECE, INCLUDING A NOVEL MUTATION-RESULTS FORM A NATIONAL REFERRAL CENTRE (2019) (0)
FRI0161 PHENOTYPIC DIFFERENCES BETWEEN SJÖGREN’S SYNDROME PATIENTS WITH LOW AND HIGH-GRADE INFLAMMATION BASED ON SALIVARY GLAND FOCUS SCORE (2020) (0)
TLR3-mediated induction of Ro/SSA and La/SSB mRNA expression in salivary gland epithelial cells (2012) (0)
Predisposing Factors, Clinical Picture, and Outcome of B-Cell Non-Hodgkin’s Lymphoma in Sjögren’s Syndrome (2022) (0)
08.16 Mir200B-5p expression in minor salivary glands (msg): a possible predictor of lymphoma development in sjögren’s syndrome (ss) (2017) (0)
POS0807 RETINAL VESSEL CALIBERS AS A NON-INVASIVE BIOMARKER OF INFLAMMATORY BURDEN IN PRIMARY SYSTEMIC VASCULITIS (2021) (0)
32 – SS-B (La) AUTOANTIBODIES (2007) (0)
The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through Synergy. (2019) (0)
Clinical Phenotype and Mechanisms of Leukopenia/Neutropenia in Patients with Primary Sjögren’s Syndrome (2022) (0)
Incorrect Spelling of Author Name in the Article by Seror et al (Arthritis Care Res [Hoboken], April 2010) (2013) (0)
SAT0207 DEVELOPMENT OF QUESTIONNAIRES TO ASSESS HEALTHCARE UTILIZATION AND ACCESS IN PATIENTSWITH PRIMARY SJöGREN’S SYNDROME AT THE DIAGNOSIS AND DURING THE DISEASE COURSE (2019) (0)
Towards the identification of novel autoantibodies in Sjögren's syndrome. (2022) (0)
Tocilizumab: an effective and low-cost treatment for recent-onset active moderate to severe graves orbitopathy. a case report (2022) (0)
Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity (2015) (0)
Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al (2022) (0)
AB0208 ASSOCIATION OF RHEUMATOID FACTOR, HLA-DRB1 SHARED EPITOPE (SE) AND SMOKING WITH RADIOGRAPHIC OUTCOME IN RHEUMATOID ARTHRITIS (2020) (0)
THU0243 Proper Initiation of Biologic Treatment (TREAT-TO-TARGET STRATEGY) Favors Better Outcome in Patients with Rheumatoid Arthritis (2014) (0)
Diagnosis and Management of a Young Girl With Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS) Linked to a Novel Mutation (2020) (0)
Autoimmunity: pathogenetic aspects. (1996) (0)
A federated AI-empowered platform for disease management across a Pan-European data driven hub (2022) (0)
SS-B (La) AUTOANTIBODIES (2014) (0)
OP0096 THE DIFFERENCES BETWEEN SJÖGREN’S SYNDROME PATIENTS WITH COMBINED SERONEGATIVITY AND ANTI-RO/SSA SEROPOSITIVITY (2020) (0)
Levels of miRNA miR200b-5p (miR200b*) in the minor salivary glands (MSG) of patients with Sjögren’s syndrome: Possible prognostic value for future lymphoma development? (2016) (0)
OP0041 SALIVA AND SERUM LEVELS OF CXCL13: ASSOCIATION WITH THE SEVERITY OF SALIVARY GLAND LESIONS AND LYMPHOMA IN PATIENTS WITH SJÖGREN’S SYNDROME (SS) (2021) (0)
Antisynthetase syndrome Author : Doctor (2005) (0)
SAT0128 Biologic Treatment is Associated with More Serious Adverse Reactions, Serious Infections and Admissions in Hospital than DMARDS in Patients with Rheumatoid Arthritis: A REAL World Study (2014) (0)
OP0029 NEUTROPHIL EXTRACELLULAR TRAPS IN GIANT CELL ARTERITIS INFLAMED TEMPORAL ARTERIES: LOCALIZATION, CO-EXPRESSION OF INFLAMMATORY CYTOKINES AND ASSOCIATION WITH DISEASE EXTENSION (2021) (0)
P0438PREDICTORS OF TREATMENT RESPONSE AND LONG-TERM OUTCOME IN PATIENTS WITH PAUCI-IMMUNE GLOMERULONEPHRITIS AND SEVERE RENAL DYSFUNCTION AT DIAGNOSIS (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Athanasios George Tzioufas?

Athanasios George Tzioufas is affiliated with the following schools:

Athanasios George Tzioufas's Academic­Influence.com Rankings

Why Is Athanasios George Tzioufas Influential?

Athanasios George Tzioufas's Published Works

Published Works

What Schools Are Affiliated With Athanasios George Tzioufas?

Athanasios George Tzioufas's AcademicInfluence.com Rankings